About Sequent Medical
Sequent Medical is a company based in Aliso Viejo (United States) founded in 2007 was acquired by Terumo Medical in June 2016. Sequent Medical has raised $65.26 million across 7 funding rounds from investors including HHS, Terumo Medical and Delphi Ventures. The company has 1,028 employees as of December 31, 2021. Sequent Medical operates in a competitive market with competitors including Rapid Medical, CoAxia, Cerus Endovascular, Anaconda Biomed and Oxford Endovascular, among others.
- Headquarter Aliso Viejo, United States
- Employees 1028 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Microvention, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$65.26 M (USD)
in 7 rounds
-
Latest Funding Round
$1.05 M (USD), Grant
Jun 01, 2016
-
Investors
HHS
& 5 more
-
Employee Count
1028
as on Dec 31, 2021
-
Acquired by
Terumo Medical
(Jun 14, 2016)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Sequent Medical
Unlock access to complete
Software Development Team
6 people
Leadership Team
5 people
Legal and Compliance
5 people
Human Resources and Administration
3 people
Operations Team
3 people
Sales and Marketing
2 people
Product Management Team
1 people
Data Analysis and Operations Team
1 people
Unlock access to complete
Funding Insights of Sequent Medical
Sequent Medical has successfully raised a total of $65.26M across 7 strategic funding rounds. The most recent funding activity was a Grant round of $1.05 million completed in June 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Sequent Medical
Sequent Medical has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, Terumo Medical and Delphi Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made in life sciences firms across all stages.
|
Locked | Locked | Locked | |
|
Life science & tech focused VC firm investing in the US
|
Locked | Locked | Locked | |
|
VC firm that focuses on early stage investments in the US
|
Locked | Locked | Locked |
Investor details for Sequent Medical
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sequent Medical
Investment portfolio details for Sequent Medical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Sequent Medical
Detailed financials for Sequent Medical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sequent Medical Comparisons
Peer comparison for Sequent Medical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Sequent Medical
Sequent Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Rapid Medical, CoAxia, Cerus Endovascular, Anaconda Biomed and Oxford Endovascular, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Neurovascular interventional devices including distal access catheters are developed.
|
|
| Locked | Locked | Locked |
Catheter-based treatment for cerebral ischemia
|
|
| Locked | Locked | Locked |
Interventional neuroradiology devices are developed for minimally invasive aneurysm treatment.
|
|
| Locked | Locked | Locked |
Medical devices for mechanical thromboectomy and clot removal are developed.
|
|
| Locked | Locked | Locked |
Metallic mesh devices for brain aneurysms are developed.
|
|
| Locked | Locked | Locked |
A hybrid polymer-metal stent for brain aneurysms is developed.
|
Detailed competitors of Sequent Medical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sequent Medical
Complete news archive for Sequent Medical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sequent Medical
Sequent Medical was founded in 2007 and raised its 1st funding round 2 years after it was founded.
Sequent Medical is headquartered in Aliso Viejo, United States. It is registered at Aliso Viejo, California, United States.
Sequent Medical is a funded company, having raised a total of $65.26M across 7 funding rounds to date.
As of Dec 31, 2021, the latest employee count at Sequent Medical is 1,028.
Sequent Medical was founded in 2007 as a privately held, development-stage company in the medical device sector. Catheter-based neurovascular technologies are developed, with the WEB Aneurysm Embolization System serving as the flagship implantable device for bridging aneurysms. CE Mark approval has been obtained in Europe, while US FDA approval remains pending. Operations are based in Aliso Viejo, United States.
Sequent Medical's top competitors include Rapid Medical, Fluid Biomed and Anaconda Biomed.
Sequent Medical has 6 investors. Key investors include HHS, Terumo Medical, Delphi Ventures, Domain Associates, and USVP.